Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cytocom to Become Statera BioPharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cytocom to Become Statera BioPharma

New name reflects strategic focus on addressing autoimmune and inflammatory diseases, blood disorders, infectious disease and cancer.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cytocom, Inc., a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, plans to change its name to Statera BioPharma, Inc. effective September 1, 2021. As part of the name change, Statera BioPharma plans to release a new company logo and launch a new company website at www.staterabiopharma.com. The new corporate name, Statera, taken from the Latin word for “balance,” and tagline “Restoring Immune Health” was chosen to better reflect the company’s strategic focus on addressing autoimmune and inflammatory diseases, blood disorders, infectious disease and cancer.

Cytocom, Inc. emerged as a publicly-traded entity following the merger between the former Cleveland BioLabs and the formerly private Cytocom Inc., completed on July 27, 2021.

“The new corporate name, Statera BioPharma and updated ticker symbol mark the latest event in a transformative year for the company,” said Michael K. Handley, President and CEO of Cytocom. “The completion of the recent merger transaction brought together two companies and promising technology platforms to create a potential powerhouse in the immune modulation field with one of the largest pipelines of toll-like immune receptors in the biopharmaceuticals industry. Our new name emphasizes the work underway as we advance our late-stage clinical assets that are designed to restore immune health.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters